33
|
131
|
1kzwA |
Solution structure of human intestinal fatty acid binding protein |
33
|
132
|
1bwyA |
Nmr study of bovine heart fatty acid binding protein |
33
|
135
|
1jbhA |
Solution structure of cellular retinol binding protein type-i in the ligand-free state |
11
|
131
|
1aelA |
Nmr structure of apo intestinal fatty acid-binding protein, 20 structures |
25
|
157
|
1jzuA |
Cell transformation by the myc oncogene activates expression of a lipocalin: analysis of the gene (q83) and solution structure of its protein product |
26
|
162
|
1dv9A |
Structural changes accompanying ph-induced dissociation of the b-lactoglobulin dimer |
16
|
137
|
1blrA |
Nmr solution structure of human cellular retinoic acid binding protein-type ii, 22 structures |
11
|
134
|
1b4mA |
Nmr structure of apo cellular retinol-binding protein ii, 24 structures |
38
|
135
|
1kglA |
Solution structure of cellular retinol binding protein type-i in complex with all-trans-retinol |
29
|
131
|
1jjxA |
Solution structure of recombinant human brain-type fatty acid binding protein |
23
|
137
|
1bm5A |
The solution structure of a site-directed mutant (r111m) of human cellular retionic acid binding protein-type ii, nmr, 31 structures |
17
|
127
|
1ealA |
Nmr study of ileal lipid binding protein |
5
|
116
|
1a57A |
The three-dimensional structure of a helix-less variant of intestinal fatty acid binding protein, nmr, 20 structures |
30
|
131
|
1kzxA |
Solution structure of human intestinal fatty acid binding protein with a naturally-occurring single amino acid substitution (a54t) |
11
|
134
|
1eiiA |
Nmr structure of holo cellular retinol-binding protein ii |
30
|
162
|
1df3A |
Solution structure of a recombinant mouse major urinary protein |
39
|
127
|
1eioA |
Ileal lipid binding protein in complex with glycocholate |
15
|
162
|
1cj5A |
Bovine beta-lactoglobulin a |
34
|
133
|
1jjjA |
Solution structure of recombinant human epidermal-type fatty acid binding protein |
21
|
132
|
1g5wA |
Solution structure of human heart-type fatty acid binding protein |
27
|
121
|
5irwA |
Crystal structure of avidin in complex with 1-desthiobiotinylpyrene |
49
|
184
|
3tgbA |
Crystal structure of l130r mutant of nitrophorin 4 from rhodnius prolixus complexed with imidazole at ph 7.4 |
42
|
174
|
3tzsA |
Crystal structure of neutrophil gelatinase-associated lipocalin ngal (c87s mutant) in complex with fragment 1026, phenylurea |
38
|
175
|
3u0dA |
The structure of human siderocalin bound to the bacterial siderophore 2,3-dhba |
50
|
184
|
3tgcA |
Crystal structure of l130r mutant of nitrophorin 4 from rhodnius prolixus complexed with nitrite at ph 7.4 |
42
|
174
|
3u03A |
The structure of human siderocalin bound to the bacterial siderophore pyochelin |
24
|
121
|
3t6fA |
Biotin complex of y54f core streptavidin |
55
|
247
|
2vdfA |
Structure of the opca adhesion from neisseria meningitidis determined by crystallization from the cubic mesophase |
71
|
361
|
2fkjA |
The crystal structure of engineered ospa |
33
|
134
|
5ljkA |
Crystal structure of human apo crbp1 |
36
|
134
|
5ljcA |
Crystal structure of holo human crbp1 |
24
|
125
|
5l8nA |
Crystal structure of human fabp6 protein with fragment 1 |
35
|
134
|
5ljbA |
Crystal structure of holo human crbp1 |
23
|
125
|
5l8oA |
Crystal structure of human fabp6 in complex with cholate |
33
|
134
|
5ljhA |
Crystal structure of human apo crbp1/k40l mutant |
39
|
162
|
5lkeA |
Bovine beta-lactoglobulin complex with myristic acid, ambient pressure |
37
|
134
|
5ljeA |
Crystal structure of holo human crbp1/k40l,q108l mutant |
26
|
123
|
5l3yA |
Designed artificial cupredoxins |
39
|
173
|
5khpA |
Tightening the recognition of tetravalent zr and th complexes by the siderophore-binding mammalian protein siderocalin for theranostic applications |
33
|
163
|
5k06A |
Recombinant bovine beta-lactoglobulin with uncleaved n-terminal methionine (rblgb) |
40
|
173
|
5kidA |
Tightening the recognition of tetravalent zr and th complexes by the siderophore-binding mammalian protein siderocalin for theranostic applications |
41
|
173
|
5kicA |
Long-sought stabilization of berkelium(iv) in solution: an anomaly within the heavy actinide series |
44
|
173
|
5jr8A |
Disposal of iron by a mutant form of siderocalin ngal |
27
|
123
|
5k67A |
Designed artificial cupredoxins |
43
|
168
|
5ixgA |
Crystal structure of burkholderia cenocepacia bcnb |
35
|
162
|
5io5A |
Unliganded form of bovine beta-lactoglobulin, ambient pressure |
32
|
162
|
5io7A |
Bovine beta-lactoglobulin complex with dodecane at high pressure (0.43 gpa) |
32
|
162
|
5io6A |
Bovine beta-lactoglobulin complex with dodecane, ambient pressure |
33
|
135
|
5hz8A |
Fabp4_3 in complex with 6,8-dichloro-4-phenyl-2-piperidin-1-yl-quinoline-3-carboxylic acid |
29
|
135
|
5hz9A |
Human fabp3 in complex with 6-chloro-2-methyl-4-phenyl-quinoline-3-carboxylic acid |